Opening of enrollment in US of Phase I CRC study announced today at
Options
coloCan
Member Posts: 1,944 Member
www.prnewswire.com
title: Oncolytics Biotech Inc Announces Opening of Enrollment in US Phase I Colorectal Cancer Study
This involves using REOLYSIN (this firm's drug) in combo with FOLFIRI for those with oxaliplatin refractory/intolerant Kras mutant CRC
Meanwhile,a company called Pro-Pharma seems to be getting positive feedback from FDA for Phase III trial design for DAVANAT, which is its CRC drug in progress.......see:businesswire.com
dont know if this will help anyone......steve
title: Oncolytics Biotech Inc Announces Opening of Enrollment in US Phase I Colorectal Cancer Study
This involves using REOLYSIN (this firm's drug) in combo with FOLFIRI for those with oxaliplatin refractory/intolerant Kras mutant CRC
Meanwhile,a company called Pro-Pharma seems to be getting positive feedback from FDA for Phase III trial design for DAVANAT, which is its CRC drug in progress.......see:businesswire.com
dont know if this will help anyone......steve
0
Comments
-
Thanks Steve
You are a gem to keep up with all the latest and greatest and keeping everyone here in the loop.
Thanks for being you.
Marie who loves kitties0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards